Is the rush to roll out a coronavirus vaccine undermining safety?

Some shortcuts are being taken in the race to get a coronavirus vaccine approved, but there are also more resources, openness and scrutiny than ever before

By Michael Le Page

US PRESIDENT Donald Trump is considering allowing the usual procedures to be bypassed so an experimental coronavirus vaccine can be made available to the public in time for the US election in November, according to a report in the Financial Times. AstraZeneca, the drug company developing the vaccine in partnership with the University of Oxford, has said there have been no talks with the US government about fast-tracking the vaccine.

But the race to develop a coronavirus vaccine is …